Current Infectious Disease Reports Q2 Unclaimed
Current Infectious Disease Reports provides in-depth review articles contributed by international experts on the most significant developments in the field. By presenting clear, insightful, balanced reviews that emphasize recently published papers of major importance, the journal elucidates current and emerging approaches to the diagnosis, treatment, management, and prevention of infectious disease. Offers the views of experts on current advances in the infectious disease field Highlights the most important recent papers from a wealth of original publications Also provides supplementary reviews featuring recently published clinical trials, valuable web sites, and commentaries from well-known figures in the field It has an SJR impact factor of 0,97.
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy: Open Choice
Type of publications:
Publication frecuency: -
3060 €
Inmediate OANPD
Embargoed OA0 €
Non OAMetrics
0,97
SJR Impact factor54
H Index19
Total Docs (Last Year)114
Total Docs (3 years)1495
Total Refs422
Total Cites (3 years)114
Citable Docs (3 years)3.34
Cites/Doc (2 years)78.68
Ref/DocOther journals with similar parameters
Microbes and Infection Q2
BMC Infectious Diseases Q2
Virus Research Q2
Infection Control and Hospital Epidemiology Q2
Retrovirology Q2
Compare this journals
Aims and Scope
Best articles by citations
Impact of antimicrobial resistance on the treatment of invasive pneumococcal infections
View moreManagement of antiretroviral therapy in neonates, children, and adolescents
View moreThe Importance of Colonization with Clostridium difficile on Infection and Transmission
View moreHealth Care-Associated Infective Endocarditis: a Growing Entity that Can Be Prevented
View moreAfrican trypanosomiasis: Changing epidemiology and consequences
View moreDoes lactobacillus prevent post-antibiotic vulvovaginal candidiasis?
View moreNew insights on interactions between HIV-1 and HSV-2
View morePharmacologic aspects of new antiretroviral drugs
View moreInflammatory Markers Associated with Coronary Heart Disease in Persons with HIV Infection
View moreEstrogen replacement therapy to prevent recurrent urinary tract infection in postmenopausal women
View moreNew biomedical strategies for HIV-1 prevention in women
View moreNew fluoroquinolones: Real and potential roles
View moreImmune restoration inflammatory syndromes: The dark side of successful antiretroviral treatment
View moreHealth Considerations for HIV-Infected International Travelers
View moreWhat Is New in Antibiotic Therapy in Community-Acquired Pneumonia? An Evidence-Based Approach Focusing on Combined Therapy
View moreManagement of HIV infection in patients with substance use problems
View moreMucormycosis of the Head and Neck
View moreWhen to Start Antiretroviral Therapy
View moreHIV, Sexually Transmitted Infections, and Sexuality in Later Life
View moreOptimal management of uncomplicated skin and skin structure infections of the lower extremity
View moreDuration of antibiotic treatment for urinary tract infection
View moreAzithromycin versus penicillin in acute group A streptococcal tonsillopharyngitis
View moreAdjunctive therapies in severe sepsis and septic shock: Current place of steroids
View moreAzole Antifungal Resistance Today: Focus on Aspergillus
View more
Comments